Industry Research Reports

Home > Reports > Medical Care > Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Medical Care

Published Date: 2025-06-22

Pages: 76 Pages

Report ld: 4681790

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Tuberculosis (TB) Diagnostics Market Size(US$)

CAGR 2025-2031

4.5%

Market Size,2031

USD 4,149

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 3,186 million

Market Forecast in 2031(Value)

US$ 4,149 million

CAGR

4.5%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global Tuberculosis (TB) Diagnostics market size was US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.

Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.

The global TB diagnostics market is being propelled by the urgent need to improve disease detection and control in response to the persistent burden of tuberculosis, particularly in high-prevalence regions. Efforts to reach WHO’s End TB goals have elevated funding for TB programs, driving the rollout of advanced diagnostic tools like molecular assays , X‑ray based screening solutions with AI assistance, and point-of-care tests. Furthermore, increasing integration of TB screening within broader healthcare initiatives—such as universal healthcare coverage and integrated respiratory disease programs—has expanded testing capacity. The push to screen high-risk populations, including people living with HIV, healthcare workers, migrants, and prison inmates, has also increased demand for rapid, accurate, and decentralized diagnostic methods capable of delivering same-day results and guiding treatment decisions.

Despite significant advancements in TB diagnostics, substantial barriers continue to hinder market expansion. One major challenge is inconsistent access to cutting-edge diagnostic tools in low- and middle-income countries, where infrastructure remains limited and centralized laboratory systems struggle to support widespread deployment. Additionally, the cost of advanced molecular and imaging technologies remains a deterrent, particularly when factoring in expenses for equipment maintenance, consumables, and the specialized training required for healthcare personnel. The regulatory and logistical complexities involved in distributing diagnostic platforms—especially in remote rural areas—also slow down adoption. Finally, the co-existence of disparate diagnostic algorithms across countries, combined with variable healthcare funding and weak supply chain systems, continues to limit consistent implementation of guideline-compliant testing and undermines efforts to significantly reduce TB incidence.

Global Tuberculosis (TB) Diagnostics key players include Danaher, Roche, Thermo Fisher Scientific, BD, Abbott, etc. Global top five manufacturers hold a share about 33%. APAC is the largest market, with a share over 40%, followed by Americas and Europe, both have a share about 40 percent.

The global Tuberculosis (TB) Diagnostics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.

MARKET SEGMENTATION

By Company

Danaher
Roche
Thermo Fisher Scientific
BD
Abbott
Hologic
Qiagen
BioMerieux
Hain Lifescience
Oxford Immunotec

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Culture-Based Diagnostics
Sputum Smear Microscopy
Rapid Molecular Diagnostics
Others

Segment by Application

Diagnostic Laboratories
Hospitals

biaoTi CHAPTER OUTLINE

Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).

Chapter 2: Quantitative analysis of Tuberculosis (TB) Diagnostics market size and growth potential at global, regional, and country levels.

Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).

Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Sputum Smear Microscopy in China).

Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Hospitals in India).

Chapter 6: Regional revenue breakdown by company, type, application and customer.

Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.

Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.

Chapter 9: Actionable conclusions and strategic recommendations.

WHY THIS REPORT

Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Tuberculosis (TB) Diagnostics value chain, addressing:

- Market entry risks/opportunities by region

- Product mix optimization based on local practices

- Competitor tactics in fragmented vs. consolidated markets

biaoTi QYRESEARCH'S STRENGTHS

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Culture-Based Diagnostics

1.2.3 Sputum Smear Microscopy

1.2.4 Rapid Molecular Diagnostics

1.2.5 Others

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Diagnostic Laboratories

1.3.3 Hospitals

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region (2020-2025)

2.4 Global Tuberculosis (TB) Diagnostics Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)

2.5.2 Europe Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)

2.5.3 China Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)

2.5.4 Japan Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)

2.5.5 India Tuberculosis (TB) Diagnostics Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2020-2025)

3.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031)

3.3 Different Types Tuberculosis (TB) Diagnostics Representative Players

4 Breakdown Data by Application

4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2020-2025)

4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in Tuberculosis (TB) Diagnostics Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2020-2025)

5.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue

5.4 Global Tuberculosis (TB) Diagnostics Market Concentration Analysis

5.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2024

5.5 Global Key Players of Tuberculosis (TB) Diagnostics Head office and Area Served

5.6 Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

5.7 Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)

6.1.2.2 North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)

6.1.3.2 North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)

6.2.2.2 Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)

6.2.3.2 Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments and Downstream

6.3.1 China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)

6.3.2 China Market Size by Type

6.3.2.1 China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)

6.3.2.2 China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

6.3.3 China Market Size by Application

6.3.3.1 China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)

6.3.3.2 China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

6.3.4 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments and Downstream

6.4.1 Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)

6.4.2 Japan Market Size by Type

6.4.2.1 Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)

6.4.2.2 Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

6.4.3 Japan Market Size by Application

6.4.3.1 Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)

6.4.3.2 Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

6.4.4 Japan Market Trend and Opportunities

6.5 India Market: Players, Segments and Downstream

6.5.1 India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025)

6.5.2 India Market Size by Type

6.5.2.1 India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025)

6.5.2.2 India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

6.5.3 India Market Size by Application

6.5.3.1 India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025)

6.5.3.2 India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

6.5.4 India Market Trend and Opportunities

7 Key Players Profiles

7.1 Danaher

7.1.1 Danaher Company Details

7.1.2 Danaher Business Overview

7.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction

7.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.1.5 Danaher Recent Development

7.2 Roche

7.2.1 Roche Company Details

7.2.2 Roche Business Overview

7.2.3 Roche Tuberculosis (TB) Diagnostics Introduction

7.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.2.5 Roche Recent Development

7.3 Thermo Fisher Scientific

7.3.1 Thermo Fisher Scientific Company Details

7.3.2 Thermo Fisher Scientific Business Overview

7.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction

7.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.3.5 Thermo Fisher Scientific Recent Development

7.4 BD

7.4.1 BD Company Details

7.4.2 BD Business Overview

7.4.3 BD Tuberculosis (TB) Diagnostics Introduction

7.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.4.5 BD Recent Development

7.5 Abbott

7.5.1 Abbott Company Details

7.5.2 Abbott Business Overview

7.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction

7.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.5.5 Abbott Recent Development

7.6 Hologic

7.6.1 Hologic Company Details

7.6.2 Hologic Business Overview

7.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction

7.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.6.5 Hologic Recent Development

7.7 Qiagen

7.7.1 Qiagen Company Details

7.7.2 Qiagen Business Overview

7.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction

7.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.7.5 Qiagen Recent Development

7.8 BioMerieux

7.8.1 BioMerieux Company Details

7.8.2 BioMerieux Business Overview

7.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction

7.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.8.5 BioMerieux Recent Development

7.9 Hain Lifescience

7.9.1 Hain Lifescience Company Details

7.9.2 Hain Lifescience Business Overview

7.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction

7.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.9.5 Hain Lifescience Recent Development

7.10 Oxford Immunotec

7.10.1 Oxford Immunotec Company Details

7.10.2 Oxford Immunotec Business Overview

7.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction

7.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025)

7.10.5 Oxford Immunotec Recent Development

8 Tuberculosis (TB) Diagnostics Market Dynamics

8.1 Tuberculosis (TB) Diagnostics Industry Trends

8.2 Tuberculosis (TB) Diagnostics Market Drivers

8.3 Tuberculosis (TB) Diagnostics Market Challenges

8.4 Tuberculosis (TB) Diagnostics Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market Tuberculosis (TB) Diagnostics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global Tuberculosis (TB) Diagnostics Revenue Share by Region (2020-2025)

Table 6. Global Tuberculosis (TB) Diagnostics Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global Tuberculosis (TB) Diagnostics Revenue Share Forecast by Region (2026-2031)

Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2020-2025)

Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2020-2025)

Table 15. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in Tuberculosis (TB) Diagnostics Application

Table 18. Global Tuberculosis (TB) Diagnostics Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Tuberculosis (TB) Diagnostics Market Share by Players (2020-2025)

Table 20. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)

Table 21. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Tuberculosis (TB) Diagnostics, Headquarters and Area Served

Table 24. Global Key Players of Tuberculosis (TB) Diagnostics, Product and Application

Table 25. Global Key Players of Tuberculosis (TB) Diagnostics, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)

Table 29. North America Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)

Table 33. Europe Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 35. China Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 36. China Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)

Table 37. China Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 38. China Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 39. Japan Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 40. Japan Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)

Table 41. Japan Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 42. Japan Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 43. India Tuberculosis (TB) Diagnostics Revenue by Company (2020-2025) & (US$ Million)

Table 44. India Tuberculosis (TB) Diagnostics Revenue Market Share by Company (2020-2025)

Table 45. India Tuberculosis (TB) Diagnostics Market Size by Type (2020-2025) & (US$ Million)

Table 46. India Tuberculosis (TB) Diagnostics Market Size by Application (2020-2025) & (US$ Million)

Table 47. Danaher Company Details

Table 48. Danaher Business Overview

Table 49. Danaher Tuberculosis (TB) Diagnostics Product

Table 50. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 51. Danaher Recent Development

Table 52. Roche Company Details

Table 53. Roche Business Overview

Table 54. Roche Tuberculosis (TB) Diagnostics Product

Table 55. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 56. Roche Recent Development

Table 57. Thermo Fisher Scientific Company Details

Table 58. Thermo Fisher Scientific Business Overview

Table 59. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product

Table 60. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 61. Thermo Fisher Scientific Recent Development

Table 62. BD Company Details

Table 63. BD Business Overview

Table 64. BD Tuberculosis (TB) Diagnostics Product

Table 65. BD Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 66. BD Recent Development

Table 67. Abbott Company Details

Table 68. Abbott Business Overview

Table 69. Abbott Tuberculosis (TB) Diagnostics Product

Table 70. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 71. Abbott Recent Development

Table 72. Hologic Company Details

Table 73. Hologic Business Overview

Table 74. Hologic Tuberculosis (TB) Diagnostics Product

Table 75. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 76. Hologic Recent Development

Table 77. Qiagen Company Details

Table 78. Qiagen Business Overview

Table 79. Qiagen Tuberculosis (TB) Diagnostics Product

Table 80. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 81. Qiagen Recent Development

Table 82. BioMerieux Company Details

Table 83. BioMerieux Business Overview

Table 84. BioMerieux Tuberculosis (TB) Diagnostics Product

Table 85. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 86. BioMerieux Recent Development

Table 87. Hain Lifescience Company Details

Table 88. Hain Lifescience Business Overview

Table 89. Hain Lifescience Tuberculosis (TB) Diagnostics Product

Table 90. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 91. Hain Lifescience Recent Development

Table 92. Oxford Immunotec Company Details

Table 93. Oxford Immunotec Business Overview

Table 94. Oxford Immunotec Tuberculosis (TB) Diagnostics Product

Table 95. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2020-2025) & (US$ Million)

Table 96. Oxford Immunotec Recent Development

Table 97. Tuberculosis (TB) Diagnostics Market Trends

Table 98. Tuberculosis (TB) Diagnostics Market Drivers

Table 99. Tuberculosis (TB) Diagnostics Market Challenges

Table 100. Tuberculosis (TB) Diagnostics Market Restraints

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

List of Figures

Figure 1. Tuberculosis (TB) Diagnostics Product Picture

Figure 2. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2024 VS 2031

Figure 3. Culture-Based Diagnostics Features

Figure 4. Sputum Smear Microscopy Features

Figure 5. Rapid Molecular Diagnostics Features

Figure 6. Others Features

Figure 7. Global Tuberculosis (TB) Diagnostics Market Share by Application: 2024 VS 2031

Figure 8. Diagnostic Laboratories

Figure 9. Hospitals

Figure 10. Tuberculosis (TB) Diagnostics Report Years Considered

Figure 11. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 12. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Region: 2020 VS 2024

Figure 14. North America Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 15. Europe Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 16. China Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Japan Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. India Tuberculosis (TB) Diagnostics Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2024

Figure 20. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2024

Figure 22. North America Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

Figure 23. North America Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

Figure 24. Europe Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

Figure 25. Europe Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

Figure 26. China Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

Figure 27. China Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

Figure 28. Japan Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

Figure 29. Japan Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

Figure 30. India Tuberculosis (TB) Diagnostics Market Share by Type (2020-2025)

Figure 31. India Tuberculosis (TB) Diagnostics Market Share by Application (2020-2025)

Figure 32. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 33. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 34. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 35. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 36. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 37. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 38. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 39. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 40. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 41. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2020-2025)

Figure 42. Bottom-up and Top-down Approaches for This Report

Figure 43. Data Triangulation

Figure 44. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

What is the annual compound growth rate of the global Tuberculosis (TB) Diagnostics market size from 2025 to 2031? zhanKai

The annual compound growth rate of the global Tuberculosis (TB) Diagnostics market is 4.5% 2025 to 2031.

Which region is expected to have the highest market share? shouQi

Which companies rank high in the global Tuberculosis (TB) Diagnostics market? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2031? shouQi

What was the global market size of Tuberculosis (TB) Diagnostics in 2025? shouQi

Related Reports

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 76
USD 4250.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 110
USD 2900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 88
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-09-11
Pages: 126
USD 4900.00
(Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-06-22
Pages: 98
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3186 million in 2025 to US$ 4149 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published Date: 2025-06-22
Pages: 121
USD 4900.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2025
The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published Date: 2025-06-22
Pages: 74
USD 2900.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 128
USD 5900.00
(Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 94
USD 3950.00
(Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published Date: 2024-04-17
Pages: 153
USD 5600.00
(Single User License)

Global Tuberculosis (TB) Diagnostics Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Tuberculosis (TB) Diagnostics market size was US$ 3186 million in 2025 and is forecast to reach a readjusted size of US$ 4318 million by 2032 with a CAGR of 4.5% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 76
USD 4250.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2026
The global Tuberculosis (TB) Diagnostics market was valued at US$ 3186 million in 2025 and is anticipated to reach US$ 4318 million by 2032, at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 110
USD 2900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3186 million in 2025 and is projected to reach US$ 4318 million, growing at a CAGR of 4.5% from 2026 to 2032.
Published: 2026-01-04
Pages: 88
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3070 million in 2024 to US$ 4149 million by 2031, at a CAGR of 4.5% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-09-11
Pages: 126
USD 4900.00 (Single User License)
Tuberculosis (TB) Diagnostics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 3070 million in 2024 and is forecast to a readjusted size of US$ 4149 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-06-22
Pages: 98
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Insights, Forecast to 2031
The global Tuberculosis (TB) Diagnostics market is projected to grow from US$ 3186 million in 2025 to US$ 4149 million by 2031, at a Compound Annual Growth Rate (CAGR) of 4.5% during the forecast period.
Published: 2025-06-22
Pages: 121
USD 4900.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Research Report 2025
The global market for Tuberculosis (TB) Diagnostics was valued at US$ 3070 million in the year 2024 and is projected to reach a revised size of US$ 4149 million by 2031, growing at a CAGR of 4.5% during the forecast period.
Published: 2025-06-22
Pages: 74
USD 2900.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million and is forecast to reach approximately US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 128
USD 5900.00 (Single User License)
Tuberculosis (TB) Diagnostics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Tuberculosis (TB) Diagnostics was estimated to be worth US$ 2870 million in 2024 and is forecast to a readjusted size of US$ 3889 million by 2031 with a CAGR of 4.5% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 94
USD 3950.00 (Single User License)
Global Tuberculosis (TB) Diagnostics Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected. The classic symptoms of active TB are a chronic cough with blood-containing sputum, fever, night sweats, and weight loss. The historical term "consumption" came about due to the weight loss. Infection of other organs can cause a wide range of symptoms.
Published: 2024-04-17
Pages: 153
USD 5600.00 (Single User License)